Please find all related articles below.
In advance of the European Commission’s legislative proposal on the recast of the Medical Devices Directive to be released in September, EPHA releases a Briefing on Medical Devices that summarises some of the issues that will be under discussion in the upcoming reform process.
As the recent PIP breast implant scandal brought to light, there has been a dramatic increase in faulty medical devices over the last decade that were able to enter the market due to serious loopholes in the (...)
What are the universal issues uniting healthcare professionals and policy-makers globally? How are people and organisations coming together and creating innovative solutions to major healthcare challenges? How will different healthcare players benefit from this? These and many other questions will be debated at the inaugural Global Healthcare Summit taking place on November 29th and 30th 2012 in London. Global Healthcare Summit that is taking place on November 29th and 30th 2012 in London (...)
Development and Health
poverty and health
The European Commission has published its draft proposal to revise the Clinical Trial Directive.
According to the European Commission, the main aim of the revised proposal is to simplify the rules for conducting clinical trials in Europe, while maintaining the highest standards of patient safety.
Once adopted, the proposed Regulation will replace the 2001 ’Clinical Trials Directive’. The objective is to ensure that Clinical Trials rules are identical throughout the EU.
Along with the European Commission, Ashoka (the worlds’ oldest and biggest network of social entrepreneurs) and Generali Future Fund present the award ‘European Social Entrepreneur of Active Ageing and Solidarity Between Generations’.
The award recognises individuals who have developed exceptional models to solve a social problem regarding active aging and solidarity between generations. The models should be replicable elsewhere and have the potential to improve (...)
EPHA released its position on Horizon 2020. This document is a result, jointly with its members, to provide the public health opinion in light of the negotiations on Horizon 2020 programme. EPHA welcomes public health priorities recommended by the European Commission. The public health community encourages EU and national decision makers to support the health theme, efforts to promote coordination and access to data.
EPHA Position on Horizon 2020
In a different approach to Innovation, (...)
Health literacy is vital to active and informed healthcare issues and is identified as a key action to reduce health inequalities within the European Union. In this context the European Centre for Disease Prevention and Control (ECDC) has published a paper providing rapid review of the evidence on the effectiveness of interventions to improve health literacy.
The ECDC report focuses on communicable diseases and interventions for disadvantaged populations within the European region. The (...)
The latest (65th) World Health Assembly gathered on 26 May adopted 21 resolutions on a broad range of health issues including: early marriages and pregnancies, the International Health Regulations, mass gatherings, the Millennium Development Goals, non communicable diseases, pandemic influenza preparedness, intensification of the global polio eradication initiative, research and development, nutrition, the social determinants of health and substandard/spurious/falsely (...)
Despite its initial ambition to seek solutions in market-driven innovation and research in accessing to safe, clean and affordable water and sanitation, the European Commission proposal (released last 14 May 2012) on the European Innovation Partnership (EIP) on Water only strengthens a vision of water as a commodity and not as a public good. EPHA evaluates the proposal Against the background of its support to the European Citizens’ Initiative Right to Water.
Read the Commission (...)
The second Flu Summit organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place on 23 March 2012. The event explored new concepts and ideas for bringing together all stakeholders in the fight against flu - both seasonal and pandemic.
Taking off where the ESWI’s First Flu Summit wound up a year ago, the event once again brought together researchers and academics, policy-makers, NGOs, health professionals and industry representatives to debate a (...)
The Health Action International (HAI) Europe (1), and the Trans-Atlantic Consumer Dialogue (2) are co-ordinating a lunch debate on the subject of “Opening up medical research data for an ethical and efficient EU policy.”
The debate will feature Prof. Dr. Wolf-Dieter Ludwig, Chairman at the Drug Commission of the German Medical Association, and Dr. Peter G°tzsche, Director of the Nordic Cochrane Centre as well as responses from the European Commission, the European Ombudsman and (...)